Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Fetal skin has unique immune cells different from adult skin.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

TNF-alpha inhibitors can cause various immune-related skin issues.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.

A rare type of skin lymphoma was identified, affecting hair follicles and sweat glands.

Belatacept may be a promising treatment for alopecia areata.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

γδ T cells adapt uniquely to different tissues in mice.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Blocking certain immune signals can reduce skin damage from radiation therapy.

ILC1 cells contribute to hair loss in alopecia areata.